Sort
261,768 grants matching “gene therapy”
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$865,861Owen W. Pornillos · Utah State Higher Education System--University Of Utah · U54 · FY2025 · AI
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
$865,843Douglas J Sheffler · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AA
TRAUMA PRIMES CELLS
$865,843University Of Colorado Denver · P50 · FY2001 · GM
Genomic Classification of Human Liver Cancer
$865,803Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Cancer stem cells and human liver cancer
$865,803Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Engineering human islet-like organoids for transplantation
$865,800Ronald M. Evans · Salk Institute For Biological Studies · R01 · FY2018 · DK
Project 3: Characterization of the biology of non-responders using Imaging and molecular analysis to inform treatment
$865,755Laura J Van't Veer · University Of California, San Francisco · P01 · FY2023 · CA
Controlling Neuropilin-2 Signaling to Improve Lymphatic Function
$865,694Diane Renee Bielenberg · Boston Children'S Hospital · R01 · FY2025 · HL
Targeting undruggable RAS for cancer treatment
$865,656Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2024 · CA
SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV
$865,618Thomas Jefferson University · P01 · FY2003 · AI
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$865,503Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2024 · AG
Systems Biology of Immune Reconstitution in HIV / AIDS
$865,426Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2010 · DA
Generation of Genotypically Diverse R5 SHIVs as Tools in HIV-1 Vaccine Research
$865,415Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R24 · FY2015 · AI
Retinal Gene Therapy
$865,383Peter Colosi · National Eye Institute · Z01 · FY2007 · EY
Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability
$865,376Chiara Federici · Biochip Labs, Inc. · R42 · FY2023 · HL
Regulation of Protein C Pathways
$865,376Laurent Olivier Mosnier · Scripps Research Institute, The · R01 · FY2024 · HL
Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability
$865,375Chiara Federici · Biochip Labs, Inc. · R42 · FY2024 · HL
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2023 · CA
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2024 · CA
Tethosomes: a non-viral DNA platform for durable expression of therapeutic transgenes in specific target cells
$865,162Benjamin Richard Hawley · Engage Biologics Inc. · R44 · FY2025 · TR
Regulation of y-secretase activity by modulatory proteins
$865,155Yueming Li · Sloan-Kettering Inst Can Research · R01 · FY2020 · AG
Mechanisms Responsible for Impairment of Neocortical Development by Cocaine
$865,109William Freed · National Institute On Drug Abuse · Z01 · FY2008 · DA
Administrative Core
$865,095Jasjit S Ahluwalia · Brown University · P20 · FY2024 · GM
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$865,070Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2021 · CA
Human pluripotent stem cells
$865,069Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS